West Pharmaceutical Services | WST - Equity Capital And Reserves

Stock Price
293.15
Daily Change
-9.05 -2.99%
Monthly
19.58%
Yearly
35.64%
Q2 Forecast
299.61

West Pharmaceutical Services reported $2.99B in Equity Capital and Reserves for its fiscal quarter ending in March of 2026.





Equity Capital And Reserves Change Date
Align Technology USD 3.96B 44.68M Sep/2025
Avanos Medical USD 778.2M 200K Dec/2025
Baxter International USD 6.13B 1.11B Dec/2025
Becton, Dickinson and Co. USD 25.28B 108M Dec/2025
Cerus USD 61.46M 6.04M Sep/2025
Charles River Laboratories USD 3.16B 240.82M Dec/2025
Cooper Companies USD 8.36B 124.7M Dec/2025
Dentsply International USD 1.34B 139M Dec/2025
Haemonetics USD 911.45M 62.28M Dec/2025
ICU Medical USD 2.12B 3.42M Dec/2025
Insulet USD 1.52B 131.1M Dec/2025
Integra LifeSciences USD 1.04B 5.89M Dec/2025
IQVIA Holdings USD 6.5B 343M Dec/2025
J&J USD 81.19B 358M Mar/2026
Medtronic USD 48.99B 128M Dec/2025
Merit Medical Systems USD 1.58B 54.9M Dec/2025
Neogen USD 2.1B 2.09M Dec/2025
OraSure Technologies USD 340.83M 21.15M Dec/2025
Quidel USD 1.92B 115.9M Dec/2025
Repligen USD 2.11B 1.66B Dec/2025
Rockwell Medical USD 30.41M 1.11M Jun/2025
Solventum Corp USD 5.05B 63M Dec/2025
STAAR Surgical USD 344.18M 9.6M Dec/2025
Terumo JPY 1.52T 84.79B Dec/2025
Utah Medical Products USD 119.27M 1.02M Dec/2025
West Pharmaceutical Services USD 2.99B 185.6M Mar/2026